Medication info
Lansotage 15/600 mg (Lansoprazole, Calcium Carbonate)

Lansotage 15/600 mg (Lansoprazole, Calcium Carbonate)

Prescription medicationTabletOral
Ingredient · strength
Lansoprazole›15mg / 1 tabletPrecipitated Calcium Carbonate›600mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
28 tablets/bottle
Approval status
Active

MFDS item code 202500564 · Approved 2025.03.14 · Insurance code 649808310

Summary

Main use
Treatment and maintenance treatment of gastroesophageal reflux disease (reflux esophagitis) and gastric and duodenal ulcers
Who takes it
Adults
Adult dose
Take this medication on an empty stomach at least 1 hour before a meal. Swallow it whole with at least half a cup of water. Do not take it with any beverage other than water. Do not chew or crush this medication. This medication 15/600mg and 30/600mg contains 15 and 30mg of lansoprazole, respectively. However, note that the amount of calcium carbonate in 2 tablets of this medication 15/600mg is not the same as that in 1 tablet of 30/600mg. 1. Short-term treatment of active duodenal ulcers: Administer 15/600 mg orally once daily for 4 weeks 2. Short-term treatment of active benign gastric ulcers: Administer 30/600 mg orally once daily for 8 weeks 3. Maintenance therapy following treatment of duodenal ulcers: Administer 15/600 mg orally once daily The duration of comparative clinical trials did not exceed 12 months. 4. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer 15/600 mg orally once daily for 8 weeks 5. Short-term treatment of erosive reflux esophagitis: Administer 30/600 mg orally once daily for 8 weeks 6. Maintenance therapy following treatment of erosive reflux esophagitis: Administer 15/600 mg orally once daily Elderly patients: Dose adjustment is necessary because clearance of this medication is reduced in elderly patients. Do not exceed a daily dose of 30 mg. Patients with hepatic impairment: Use this medication with caution, including dose adjustment, because its metabolism and excretion may be delayed in patients with hepatic impairment.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and maintenance treatment of gastroesophageal reflux disease (reflux esophagitis) and gastric and duodenal ulcers

  • Active duodenal ulcer
  • active benign gastric ulcer
  • symptoms associated with gastroesophageal reflux disease
  • erosive esophagitis
View approved original text

This medication is used for short-term treatment of active duodenal ulcers and active benign gastric ulcers. It is also used as maintenance therapy to prevent recurrence after duodenal ulcer treatment. It temporarily alleviates symptoms due to gastroesophageal reflux disease and erosive esophagitis and is used as maintenance therapy after erosive esophagitis treatment. This treatment effectively improves symptoms of gastrointestinal diseases.

How to take

Adult dose

Take this medication on an empty stomach at least 1 hour before a meal. Swallow it whole with at least half a cup of water. Do not take it with any beverage other than water. Do not chew or crush this medication. This medication 15/600mg and 30/600mg contains 15 and 30mg of lansoprazole, respectively. However, note that the amount of calcium carbonate in 2 tablets of this medication 15/600mg is not the same as that in 1 tablet of 30/600mg. 1. Short-term treatment of active duodenal ulcers: Administer 15/600 mg orally once daily for 4 weeks 2. Short-term treatment of active benign gastric ulcers: Administer 30/600 mg orally once daily for 8 weeks 3. Maintenance therapy following treatment of duodenal ulcers: Administer 15/600 mg orally once daily The duration of comparative clinical trials did not exceed 12 months. 4. Short-term treatment of symptoms associated with gastroesophageal reflux disease: Administer 15/600 mg orally once daily for 8 weeks 5. Short-term treatment of erosive reflux esophagitis: Administer 30/600 mg orally once daily for 8 weeks 6. Maintenance therapy following treatment of erosive reflux esophagitis: Administer 15/600 mg orally once daily Elderly patients: Dose adjustment is necessary because clearance of this medication is reduced in elderly patients. Do not exceed a daily dose of 30 mg. Patients with hepatic impairment: Use this medication with caution, including dose adjustment, because its metabolism and excretion may be delayed in patients with hepatic impairment.

Precautions

This medication should not be used in patients with allergic reactions to specific ingredients, those taking HIV treatments or medications containing rilpivirine, pregnant women, and patients with severe hypercalcemia or significantly impaired renal function. Care should be taken when using this medication in patients with a history of drug allergies, poor liver function, elderly patients, breastfeeding women, patients with heart or lung problems, and those with severe constipation. This medication can rarely cause serious allergic reactions, blood disorders, liver dysfunction, skin diseases, pneumonia, nephritis, and other side effects; any abnormal symptoms should prompt immediate discontinuation and consultation with a physician. During treatment, symptoms such as headaches or diarrhea may occur, with various side effects reported, including gastrointestinal disturbances, skin rashes, and shortness of breath. This medication suppresses gastric acid secretion, which may affect the absorption of other drugs; caution is needed when combined with specific medications, and a consultation with a physician is recommended. Long-term use may lead to vitamin B12 deficiency or hypomagnesemia, necessitating regular check-ups. Additionally, prolonged use of this medication may increase the risk of fractures, so it is advisable to take it at the minimum effective dose for the shortest duration necessary. Use during pregnancy is not recommended, and breastfeeding women should also avoid administration or discontinue breastfeeding. Dizziness, drowsiness, and visual disturbances may occur; caution is required when driving or operating machinery. In case of overdose, gastric lavage or treatment according to symptoms may be necessary; this medication is not removed by hemodialysis. Keep out of reach of children and take care not to transfer to other containers.

Side effects

Anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, urticaria, generalized rash, facial edema, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, headache, diarrhea, abdominal distention, allergic reaction, back pain, weakness, candidiasis, malignancy, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, fatigue, neck stiffness, pelvic pain, angina, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, abnormal stool, enteritis, gastritis, gastric abnormalities, gastrointestinal disease, gastrointestinal bleeding, anorexia, gastric stones, pyloric spasm, cholelithiasis, constipation, dry mouth, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophageal ulcer, esophagitis, stool discoloration, abdominal distension, gastric nodules, gastric mucosal polyps, gastroenteritis, gastrointestinal hemorrhage, hematemesis, increased appetite, increased saliva, anal bleeding, stomatitis, tongue disorders, glossitis, gum bleeding, delayed recovery, colitis, vomiting, nausea, gastric candidiasis, rectal disorders, rectal bleeding, diabetes mellitus, goiter, hypothyroidism, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone diseases, joint diseases, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia, ptosis, synovitis, anxiety, amnesia, panic, indifference, confusion, depression, dizziness, syncope, hallucinations, unilateral paralysis, worsening hostility, decreased libido, increased libido, neurosis, sensory disturbances, abnormal thoughts, seizures, dementia, depersonalization, diplopia, hyperkinesia, hypertonia, sensory hypoesthesia, insomnia, sleep disorders, drowsiness, tremors, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumors, pulmonary fibrosis, pharyngitis, pleural disorders, respiratory disorders, rhinitis, sinusitis, wheezing, acne, hair loss, pruritus, rash, contact dermatitis, dry skin, nail disorders, skin cancer, skin diseases, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disorders, eye disorders, glaucoma, olfactory dysfunction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, eye pain, otitis media, dysgeusia, tinnitus, visual field constriction, urination disorders, kidney pain, penile disorders, testicular disorders, urethral pain, polyuria, frequent urination, residual urine, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, kidney stones, nausea, constipation, diarrhea, rebound gastric acid secretion, hypercalcemia, alkalosis, kidney stones, urinary stones, pruritus, abdominal pain, elevated AST, elevated ALT, elevated creatinine, elevated ALP, increased globulin, elevated γ-GTP, abnormal WBC, abnormal AG ratio, abnormal RBC, hyperbilirubinemia, increased serum potassium, increased urinary potassium, crystalluria, eosinophilia, decreased hemoglobin, hyperlipidemia, increased electrolytes, decreased electrolytes, elevated cholesterol, decreased cholesterol, increased glucocorticoids, elevated LDH, increased platelets, decreased platelets, abnormal platelets, increased gastrin concentration, positive fecal occult blood test, albuminuria, hematuria, hepatotoxicity, vomiting, pancreatitis, abdominal pain, taste abnormalities, aplastic anemia, leukopenia, neutropenia, thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile-associated diarrhea, fractures, myositis, erythema multiforme, discoid lupus erythematosus, systemic lupus erythematosus, speech disorders, urinary retention, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated γ-GTP, weakness, hyponatremia, elevated total cholesterol, increased uric acid, tongue paralysis, lip paralysis, limb paralysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This will help preserve the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

28 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.